Raymond James Financial Services Advisors’s Cidara Therapeutics CDTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-3,878
Closed -$71.3K 3407
2024
Q1
$71.3K Sell
3,878
-65
-2% -$1.2K ﹤0.01% 3255
2023
Q4
$62.6K Sell
3,943
-13
-0.3% -$206 ﹤0.01% 3168
2023
Q3
$74.5K Buy
3,956
+796
+25% +$15K ﹤0.01% 3099
2023
Q2
$71.4K Sell
3,160
-323
-9% -$7.3K ﹤0.01% 3096
2023
Q1
$88.5K Sell
3,483
-200
-5% -$5.08K ﹤0.01% 3055
2022
Q4
$55.7K Sell
3,683
-751
-17% -$11.4K ﹤0.01% 3071
2022
Q3
$56K Buy
4,434
+97
+2% +$1.23K ﹤0.01% 3061
2022
Q2
$42K Buy
4,337
+23
+0.5% +$223 ﹤0.01% 3081
2022
Q1
$72K Buy
4,314
+562
+15% +$9.38K ﹤0.01% 3126
2021
Q4
$95K Sell
3,752
-715
-16% -$18.1K ﹤0.01% 3112
2021
Q3
$200K Sell
4,467
-250
-5% -$11.2K ﹤0.01% 2975
2021
Q2
$191K Buy
4,717
+382
+9% +$15.5K ﹤0.01% 3017
2021
Q1
$231K Sell
4,335
-139
-3% -$7.41K ﹤0.01% 2813
2020
Q4
$179K Sell
4,474
-430
-9% -$17.2K ﹤0.01% 2748
2020
Q3
$280K Sell
4,904
-197
-4% -$11.2K ﹤0.01% 2311
2020
Q2
$376K Buy
+5,101
New +$376K ﹤0.01% 2095
2020
Q1
Sell
-6,211
Closed -$477K 2429
2019
Q4
$477K Buy
6,211
+1,079
+21% +$82.9K ﹤0.01% 2011
2019
Q3
$205K Sell
5,132
-1,244
-20% -$49.7K ﹤0.01% 2488
2019
Q2
$214K Sell
6,376
-885
-12% -$29.7K ﹤0.01% 2491
2019
Q1
$385K Sell
7,261
-6,233
-46% -$330K ﹤0.01% 2055
2018
Q4
$634K Buy
13,494
+2,866
+27% +$135K ﹤0.01% 1520
2018
Q3
$935K Buy
10,628
+2,197
+26% +$193K ﹤0.01% 1501
2018
Q2
$877K Buy
8,431
+4,981
+144% +$518K ﹤0.01% 1504
2018
Q1
$276K Buy
3,450
+1,961
+132% +$157K ﹤0.01% 2077
2017
Q4
$203K Buy
1,489
+290
+24% +$39.5K ﹤0.01% 2255
2017
Q3
$194K Buy
1,199
+325
+37% +$52.6K ﹤0.01% 2284
2017
Q2
$131K Buy
+874
New +$131K ﹤0.01% 2305